Pfizer 2022 guidance comes shy of expectations despite strong growth projection
New York : US pharmaceutical company Pfizer Inc. has presented weaker-than-expected operating guidance for 2022 leading to material loss of its stock price.Pfizer expects to realise $98-102 billion of revenues in 2022 and the mid-point of…